Neglected Diseases

Extensive Space for Modern Drug Discovery

Maurizio Botta (Universita di Siena, Italy)

$217.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
30 October 2018

Medical research; Pharmacology; Tropical medicine; Organic chemistry

Neglected Diseases: Extensive Space for Modern Drug Discovery provides in-depth reviews on the last progresses about neglected tropical diseases research. Topics covered in this volume include Leishmaniasis, Tripanosomiasis, Onchocerciasis and Ebolavirus infections, with insights on the future of the research on them. Part of the volume is devoted to recent contributions this field received from X-Ray crystallography.

Volume editor: Maurizio Botta (Universita di Siena Italy)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 229mm, Width: 151mm,
Weight: 520g
ISBN: 9780128151433
ISBN 10: 0128151439
Pages: 240
Publication Date: 30 October 2018
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

1. Targeting Human Onchocerciasis: Recent Advances Beyond Ivermectin Stefano Sainas, Franco Dosio, D. Boschi and M.L. Lolli 2. Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis Chiara Borsari, Antonio Quotadamo, Stefania Ferrari, A. Venturelli, Anabela Cordeiro, Nuno Santarem and Maria Paola Costi 3. Drugs and Drug Resistance in African and American Trypanosomiasis Jaime Franco, Laura Scarone and Marcelo A. Comini 4. Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules Elisa Fanunza, Aldo Frau, Angela Corona and Enzo Tramontano 5. X-Ray Crystallography Contributions to Drug-Discovery Against Parasite Infections Cecilia Pozzi, Giusy Tassone and Stefano Mangani

Maurizio Botta obtained a degree with laude in Chemistry at University of Rome in 1974. In November 1977 he got the PhD at the University of New Brunswick. He has been researcher in Organic Chemistry at University of Rome (1981-1987). From November 2009 to October 2012 he was Dean of the Faculty of Pharmacy at the University of Siena. From January 2008 he is Adjunct Professor in Temple University College of Science and Technology, Philadelphia (USA) and, since 2000, he is Full Professor of Medicinal Chemistry at the Department of Biotechnology Chemistry and Pharmacy of University of Siena. Author of more than 500 papers, 26 patents, and more than 450 proceedings at congresses. EU Expert for reviewing projects belonging to the TMR research program and in the panel “Quality of Life. Member of the Editorial Board of ChemMedChem, JMedChem and JChemInfoModel, Associate Editor for MedChemLetters. Member of the Committees of several scientific Schools and Meetings. Co-founder of two spin-off (MoLiRom, LeadDiscoverySiena).